Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04700-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Md Siddiqul Islam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Southeast University, Dhaka, 1213, Bangladesh. Hauptthemen laut MEDLINE: Breast Neoplasms, NAD(P)H Dehydrogenase (Quinone), Aldehyde Dehydrogenase 1 Family, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Southeast University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Cyclophosphamide, Epirubicin/Doxorubicin, 5-fluorouracil (CEF or CAF) chemotherapy has long been a standard first-line treatment for breast cancer. The genetic variations of enzymes that are responsible for the metabolism of these drugs have been linked to altered treatment response and toxicity. Two drug-metabolizing enzymes ALDH1A1 and NQO1 are critically involved in the pathways of CEF/CAF metabolism. This study aimed to evaluate the effect of ALDH1A1 (rs13959) and NQO1 (rs1800566) polymorphisms on treatment response and toxicities caused by adjuvant (ACT) and neoadjuvant chemotherapy (NACT) where CEF/CAF combination was used to treat Bangladeshi breast cancer patients. METHODS: A total of 330 patients were recruited from various hospitals, with 150 receiving neoadjuvant chemotherapy and 180 receiving adjuvant chemotherapy. To extract genomic DNA, a non-enzymatic simple salting out approach was adopted. The polymerase chain reaction-restriction fragment length polymorphism method was used to detect genetic polymorphisms. Unconditional logistic regression was used to derive odds ratios (ORs) with 95% confidence intervals (CIs) to study the association between genetic polymorphisms and clinical outcome and toxicity. RESULTS: A statistically significant association was observed between ALDH1A1 (rs13959) polymorphism and treatment response (TT vs. CC: aOR = 6.40, p = 0.007; recessive model: aOR = 6.38, p = 0.002; allele model: p = 0.032). Patients with the genotypes TT and CT + TT of the NQO1 (rs1800566) polymorphism had a significantly higher risk of toxicities such as anemia (aOR = 0.34, p = 0.006 and aOR = 0.58, p = 0.021), neutropenia (aOR = 0.42, p = 0.044 and aOR = 0.57, p = 0.027), leukopenia (aOR = 0.33, p = 0.010 and aOR = 0.46, p = 0.005), and gastrointestinal toxicity (aOR = 0.30, p = 0.02 and aOR = 0.38, p = 0.006) when compared to the wild CC genotype, while patients with the genotype CT had a significant association with gastrointestinal toxicity (aOR = 0.42, p = 0.02) and leukopenia (aOR = 0.52, p = 0.010). The TT and CT + TT genotypes of rs13959 had a significantly higher risk of anemia (aOR = 2.00, p = 0.037 and aOR = 1.68, p = 0.029). There was no significant association between rs1800566 polymorphism and treatment response. CONCLUSION: Polymorphisms in ALDH1A1 (rs13959) and NQO1 (rs1800566) may be useful in predicting the probability of treatment response and adverse effects from CEF or CAF-based chemotherapy in breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Southeast University, Dhaka, 1213, Bangladesh.
- Department of Pharmacy, Jagannath University, Dhaka, 1100, Bangladesh.
- Department of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh.
- QUEST Bangladesh - Biomedical Research Centre, Dhaka, 1230, Bangladesh.
- Uttara Adhunik Medical College, Dhaka, 1230, Bangladesh.
- Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, 3814, Bangladesh. research_safiq@yahoo.com.
ORCID-Profile: Mohammad Safiqul Islam
Förderung
- Southeast University
Zitieren
APA
Islam, M. S., Akter, F., Rahman, M. M., Rafe, M. R., Aziz, M. A., Parvin, S., Mosaddek, A. S. M., Islam, M. S., & Akter, M. W. (2024). Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04700-5
Vancouver
Islam MS, Akter F, Rahman MM, Rafe MR, Aziz MA, Parvin S, et al. Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04700-5
BibTeX
@article{Islam2024,
author = {Islam, Md Siddiqul and Akter, Ferdowsi and Rahman, Md Mosiqur and Rafe, Md Rajdoula and Aziz, Md Abdul and Parvin, Salma and Mosaddek, Abu Syed Md and Islam, Mohammad Safiqul and Akter, Md Wahid},
title = {Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04700-5}
}
EUVIMED